Finzati - Logo
COO logo

The Cooper Companies, Inc.

COO • Medical - Instruments & Supplies
$58.16
— 0.00 (0.00%)
EarningsLatest report: Jul 31, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$11.25B
Growth
3.1%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 9.2%Positive revenue growth · 8.4%Positive free cash flow · 2.17Consistent free cash flow · 5/5Manageable debt level · 0.34
Financial data as of: Jul 31, 2026, 12:00 AM UTCLast earnings update: Jul 31, 2026, 12:00 AM UTCLast profile update: Sep 10, 2026, 12:05 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$58.16
Change0.00%
Shares Out193.40M
Market Cap$11.25B
Enterprise Value$13.64B
52W Range58.89 - 89.83
Beta0.82
P/E19.72
P/S2.65
P/B1.35
P/FCF124.15
EV/Sales3.22

Investment DNA

How strong this company looks for long-term investors

67
out of 100
Business Quality
Margins, moat, returns
59/100
Financial Strength
Debt, cash, stability
83/100
Growth Potential
Revenue and expansion
53/100
Price Attractiveness
Cheap or expensive today
59/100
Why this score▼
Stable or improving margins · 9.2%Positive revenue growth · 8.4%Positive free cash flow · 2.17Consistent free cash flow · 5/5Manageable debt level · 0.34Healthy liquidity · 1.89

Analyst view

Analyst sentiment and price target

COO
Analyst sentiment
Based on 28 analyst votes · 2026-10-20
73/100
Bullish
Bullish
14
Hold
13
Bearish
1
Price Target
2026-09-11
Low
$59.00
Mean
$65.75
Median
$63.50
High
$75.00

Company Overview

IPO: 1/21/1983
Industry: Medical - Instruments & Supplies
P/B i: 1.35
Debt / Equity i: 0.34
Operating Margin: 16.69%
Net Margin: 9.16%
ROE i: -
ROIC: -

Financial Health

Score17 / 20
Debt / Equity: 0.34
Current Ratio: 1.89
Quick Ratio: 1.13
Status: Strong

Insider Transactions

Recent executive and insider activity

Keel Paul A
Transaction: 07/01/2026
OTHER
Change
0
Price
Not reported
Filing
07/06/2026
Type
OTHER
Keel Paul A
Transaction: 07/01/2026
BUY
Change
+2,814
Price
Not reported
Filing
07/06/2026
Type
BUY
Rosebrough Walter M Jr
Transaction: 04/01/2026
SELL
Change
-832
Price
Not reported
Filing
04/21/2026
Type
SELL